Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Sawai Pharmaceutical patents

List of Sawai Pharmaceutical patents

List of Northwestern University patents

List of Sensitech Inc patents

List of Great Plains Manufacturing, Inc. patents

Founders educated at University of Southampton

List of companies in Go Capital's investment portfolio

Patents where

Current Assignee

Name

is

Sawai Pharmaceutical

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11406600 Anhydrous dasatinib-containing preparation	Patent 11406600 was granted and assigned to Sawai Pharmaceutical on August, 2022 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	11406600	August 9, 2022
	‌ US Patent 10890572 Mouthfeel evaluation method and mouthfeel evaluation apparatus for orally disintegrating test object	Patent 10890572 was granted and assigned to Sawai Pharmaceutical on January, 2021 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	10890572	January 12, 2021
	‌ US Patent 9561213 Candesartan cilexetil-containing preparation	Patent 9561213 was granted and assigned to Sawai Pharmaceutical on February, 2017 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	9561213	February 7, 2017
	‌ US Patent 10925861 Mirabegron-containing tablet, method for producing mirabegron-containing pharmaceutical preparation, and method for producing mirabegron-containing granulated product	Patent 10925861 was granted and assigned to Sawai Pharmaceutical on February, 2021 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	10925861	February 23, 2021
	‌ US Patent 10989647 Orally disintegrating tablet evaluating method, and orally disintegrating tablet evaluating device	Patent 10989647 was granted and assigned to Sawai Pharmaceutical on April, 2021 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	10989647	April 27, 2021
	‌ US Patent 9399064 Pitavastatin-containing preparation and method for producing same	Patent 9399064 was granted and assigned to Sawai Pharmaceutical on July, 2016 by the United States Patent and Trademark Office.		Sawai Pharmaceutical		United States Patent and Trademark Office	9399064	July 26, 2016
	‌ US Patent 9314454 Oral cavity disintegrating tablet and method of producing the same	Patent 9314454 was granted and assigned to Sawai Pharmaceutical on April, 2016 by the United States Patent and Trademark Office.		Sawai Pharmaceutical		United States Patent and Trademark Office	9314454	April 19, 2016
	‌ US Patent 10842760 Sustained-release preparation containing pseudoephedrine or a pharmaceutically acceptable salt thereof	Patent 10842760 was granted and assigned to Sawai Pharmaceutical on November, 2020 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	10842760	November 24, 2020
	‌ US Patent 10588856 Orally disintegrating tablet coated with film	Patent 10588856 was granted and assigned to Sawai Pharmaceutical on March, 2020 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	10588856	March 17, 2020
	‌ US Patent 8529953 Process for production of spherical microparticles comprising tamsulosin hydrochloride	Patent 8529953 was granted and assigned to Sawai Pharmaceutical on September, 2013 by the United States Patent and Trademark Office.		Sawai Pharmaceutical		United States Patent and Trademark Office	8529953	September 10, 2013
	‌ US Patent 11786472 Preparation containing saxagliptin and method for producing the same	Patent 11786472 was granted and assigned to Sawai Pharmaceutical on October, 2023 by the United States Patent and Trademark Office.	Sawai Pharmaceutical	Sawai Pharmaceutical		United States Patent and Trademark Office	11786472	October 17, 2023

11 results

0 selected

11 results

0 selected